Sign up to save your podcasts
Or
Share What is the impact of sex on treatment response in axial spondyloarthritis?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What is the impact of sex on treatment response in axial spondyloarthritis?
This study explores the impact of axial spondyloarthritis (axSpA) subtype and sex on the discontinuation of first-line biologic DMARDs (bDMARDs). The key findings indicate that patients with non-radiographic axSpA (nr-axSpA) and female patients are more likely to discontinue bDMARD therapy and exhibit lower treatment survival rates compared to their counterparts. Listen to get more details in this deep dive.
Based onRemalante-Rayco P, et al. Ann Rheum Dis 2025
and develop with NotebookLM.
View all episodes
By Dr. Denis PoddubnyyThis study explores the impact of axial spondyloarthritis (axSpA) subtype and sex on the discontinuation of first-line biologic DMARDs (bDMARDs). The key findings indicate that patients with non-radiographic axSpA (nr-axSpA) and female patients are more likely to discontinue bDMARD therapy and exhibit lower treatment survival rates compared to their counterparts. Listen to get more details in this deep dive.
Based onRemalante-Rayco P, et al. Ann Rheum Dis 2025
and develop with NotebookLM.